SKIN SQUAMOUS CELL CARCINOMA
Clinical trials for SKIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SKIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SKIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer-killing virus plus immune booster shows promise for rare skin tumors
Disease control OngoingThis study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't responded to standard care. First, patients receive a virus-based therapy (talimogene laherparepvec) that infects and kills tumor cells. Then, they also get an immunotherapy …
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New drug duo shows promise against advanced skin cancer
Disease control OngoingThis study tests whether adding cetuximab to avelumab helps people with advanced skin squamous cell carcinoma live longer without their cancer getting worse. About 60 participants will receive either avelumab alone or avelumab plus cetuximab. The goal is to see if the combination…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 19, 2026 11:48 UTC